Patents by Inventor Charles M. Beasley, Jr.

Charles M. Beasley, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating cognitive dysfunction
    Patent number: 6506746
    Abstract: The invention provides a method of treating a cognitive dysfunction comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b][1,5]benzodiazepine.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: January 14, 2003
    Assignee: Eli Lilly and Company
    Inventor: Charles M Beasley, Jr.
  • METHOD FOR TREATING COGNITIVE DYSFUNCTION
    Publication number: 20020177590
    Abstract: The invention provides a method for treating a cognitive dysfunction comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine.
    Type: Application
    Filed: November 25, 1997
    Publication date: November 28, 2002
    Inventor: CHARLES M BEASLEY JR
  • Method for treating a tic disorder
    Patent number: 6274636
    Abstract: The invention provides a method for treating a tic disorder comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine.
    Type: Grant
    Filed: February 16, 1999
    Date of Patent: August 14, 2001
    Assignee: Eli Lilly and Company
    Inventor: Charles M. Beasley, Jr.
  • Method for treating excessive aggression
    Patent number: 6071902
    Abstract: The invention provides a method for treating extreme aggression in a mammal comprising administering an effective amount of olanzapine, or a pharmaceutically acceptable salt or solvate thereof, to the mammal.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: June 6, 2000
    Assignee: Eli Lilly and Company
    Inventors: Charles M Beasley Jr., Pierre V Tran
  • Psychoactive substance disorders
    Patent number: 5817657
    Abstract: 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-?2,3-b!?1,5!benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders relating to the use of psychoactive substances.
    Type: Grant
    Filed: November 13, 1996
    Date of Patent: October 6, 1998
    Assignees: Eli Lilly and Company, Eli Lilly and Company Limited
    Inventors: Charles M. Beasley, Jr., Jiban Kumar Chakrabarti, Terrence Michael Hotten, David Edward Tupper
  • Mental disorders
    Patent number: 5817656
    Abstract: 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-?2,3-b!?1,5!benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of mental disorders.
    Type: Grant
    Filed: November 13, 1996
    Date of Patent: October 6, 1998
    Assignees: Eli Lilly and Company, Eli Lilly and Company Limited
    Inventors: Charles M. Beasley, Jr., Jiban Kumar Chakrabarti, Terrence Michael Hotten, David Edward Tupper
  • Method for treating dyskinesias with olanzapine
    Patent number: 5776928
    Abstract: The invention provides a method for treating a dyskinesias comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno?2,3-b!?1,5! benzodiazepine.
    Type: Grant
    Filed: April 21, 1995
    Date of Patent: July 7, 1998
    Assignee: Eli Lilly and Company
    Inventor: Charles M. Beasley, Jr.
  • 2-methyl-thieno-benzodiazepine
    Patent number: 5605897
    Abstract: Olanzapine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system.
    Type: Grant
    Filed: February 13, 1995
    Date of Patent: February 25, 1997
    Assignees: Eli Lilly and Company, Lilly Industries Limited
    Inventors: Charles M. Beasley, Jr., Jiban K. Chakrabarti, Terrence M. Hotten, David E. Tupper